Role of Modern Technologies in Tissue Engineering

被引：5

作者：

Ali, Qurban ^{[1
]}

Malik, Sabeen ^{[1
]}

Malik, Arif ^{[1
]}

Hafeez, Muhammad Nadeem ^{[2
]}

Salman, Said ^{[3
]}

机构：

[1] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan

[2] Univ Chieti Pescara G dAnnunzio, Dept Pharm, Chieti, Italy

[3] Gomal Univ, Dept Plant Breeding & Genet, Dera Ismail Khan, Pakistan

来源：

ARCHIVES OF NEUROSCIENCE | 2020年 / 7卷 / 01期

关键词：

Nanotechnology; Nanoparticles; Bio-Scaffolds; Tissue Engineering; Tissue Regeneration; Regenerative Medicine; CRISPR/Cas9; System; STEM-CELL THERAPY; DRUG-DELIVERY; EXTRACELLULAR-MATRIX; POLYMERIC SCAFFOLDS; GENE; CRISPR-CAS9; RNA; NANOTECHNOLOGY; CRISPR/CAS9; BIOMATERIALS;

D O I：

10.5812/ans.90394

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Nanotechnology is a rapidly developing field with numerous applications spread in different fields, especially medicine. It plays a role in tissue engineering, tissue regeneration, drug delivery, and regenerative medicine. The present brief review summarizes the role of nanotechnology in tissue engineering and tissue regeneration. The CRISPR/Cas9 system in tissue engineering is playing an important role, as CRISPR is a revolutionary genome-editing technology that is being used for tissue engineering where it emphasizes to address tissue architecture formation, immune response circumvention, cell differentiation, and disease model development. Moreover, the development and research expenses for tissue engineering and regenerative medicine are too high and there is a need for making these systems cost-effective. Thus, the advanced approach of applications of nanotechnology to regenerative medicine and CRISPR will definitely revolutionize the basis of treatment, prevention, and diagnosis of various diseases.

引用

页数：10

共 113 条

[1] A CRISPR/Cas9 Vector System for Tissue-Specific Gene Disruption in Zebrafish [J].

Ablain, Julien ;

Durand, Ellen M. ;

Yang, Song ;

Zhou, Yi ;

Zon, Leonard I. .

DEVELOPMENTAL CELL, 2015, 32 (06) :756-764

[2]

Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO

[3]

2-J

[4] New frontiers in nanotechnology for cancer treatment [J].

Alexis, Frank ;

Rhee, June-Wha ;

Richie, Jerome P. ;

Radovic-Moreno, Aleksandar F. ;

Langer, Robert ;

Farokhzad, Omid C. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (01) :74-85

[5] Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease [J].

Anders, Carolin ;

Niewoehner, Ole ;

Duerst, Alessia ;

Jinek, Martin .

NATURE, 2014, 513 (7519) :569-+

[6] Modelling motor neuron disease in fruit flies: Lessons from spinal muscular atrophy [J].

Aquilina, Beppe ;

Cauchi, Ruben J. .

JOURNAL OF NEUROSCIENCE METHODS, 2018, 310 :3-11

[7] A prudent path forward for genomic engineering and germline gene modification [J].

Baltimore, David ;

Berg, Paul ;

Botchan, Michael ;

Carroll, Dana ;

Charo, R. Alta ;

Church, George ;

Corn, Jacob E. ;

Daley, George Q. ;

Doudna, Jennifer A. ;

Fenner, Marsha ;

Greely, Henry T. ;

Jinek, Martin ;

Martin, G. Steven ;

Penhoet, Edward ;

Puck, Jennifer ;

Sternberg, Samuel H. ;

Weissman, Jonathan S. ;

Yamamoto, Keith R. .

SCIENCE, 2015, 348 (6230) :36-38

[8] Applications of CRISPR technologies in research and beyond [J].

Barrangou, Rodolphe ;

Doudna, Jennifer A. .

NATURE BIOTECHNOLOGY, 2016, 34 (09) :933-941

[9]

Becerra J, 2010, TISSUE ENG PART B-RE, V16, P617, DOI 10.1089/ten.TEB.2010.0191

[10] The fruit fly at the interface of diagnosis and pathogenic mechanisms of rare and common human diseases [J].

Bellen, Hugo J. ;

Wangler, Michael F. ;

Yamamoto, Shinya .

HUMAN MOLECULAR GENETICS, 2019, 28 (R2) :R207-R214

← 1 2 3 4 5 6 7 8 9 10 →